5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 5 of 5 clinical reviews.
A clinical guide to compounded bremelanotide as a lower-cost alternative to brand-name Vyleesi for hypoactive sexual desire disorder (HSDD), including pricing, pharmacy options, dosing, and insurance strategies.
Find out whether Medicare Part D covers Vyleesi (bremelanotide), what you can expect to pay out of pocket, and how to lower costs through manufacturer programs, compounding pharmacies, and formulary exceptions.
A complete guide to the Vyleesi (bremelanotide) manufacturer copay program, insurance coverage strategies, and alternatives that bring the $1,200 cash price down to as little as $0 per fill for eligible patients.
A guide to Vyleesi (bremelanotide) patient assistance programs, manufacturer coupons, compounding options, and insurance coverage strategies for low-income patients with HSDD.
A step-by-step guide to obtaining Vyleesi (bremelanotide) coverage through the VA healthcare system, including non-formulary request procedures, clinical justification strategies, and alternative cost-saving pathways.